Edward M. MD Kaye - 05 Aug 2022 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John Faurescu, attorney-in-fact for Dr. Kaye
Issuer symbol
CYTK
Transactions as of
05 Aug 2022
Transactions value $
-$471,405
Form type
4
Filing time
08 Aug 2022, 16:01:04
Previous filing
12 Jul 2022
Next filing
05 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $100K +11.4K +90.87% $8.75 24K 05 Aug 2022 Direct F1
transaction CYTK Common Stock Sale -$571K -11.4K -47.61% $50.00 12.6K 05 Aug 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -11.4K -100% $0.00* 0 05 Aug 2022 Common Stock 11.4K $8.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 12, 2021.